Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic
myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients
Cancer specific Type I IFN signaling is regulated by hMENA splicing, affects macrophage polarization and participates at resistance to immune checkpoint blockade
Abstract
Dissecting the tumour immune microenvironment of advanced NSCLC
Abstract
Development of novel therapeutic combinations in drug resistan braf-mutant melanomas
Abstract
Exploiting multi-omic integrated data from DC-vaccinated melanoma patients for the generation of an advanced adoptive T cell therapy
Donor-unrestricted targeting of CD1C-expressing leukemia by T and INKT cells engineered with lipid-specific TC
Abstract
IT
EN